GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Span-America Medical Systems Inc (NAS:SPAN) » Definitions » Debt-to-EBITDA

Span-America Medical Systems (Span-America Medical Systems) Debt-to-EBITDA : 0.00 (As of Mar. 2017)


View and export this data going back to 1983. Start your Free Trial

What is Span-America Medical Systems Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Span-America Medical Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $0.00 Mil. Span-America Medical Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $0.00 Mil. Span-America Medical Systems's annualized EBITDA for the quarter that ended in Mar. 2017 was $9.62 Mil. Span-America Medical Systems's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2017 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Span-America Medical Systems's Debt-to-EBITDA or its related term are showing as below:

SPAN's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.245
* Ranked among companies with meaningful Debt-to-EBITDA only.

Span-America Medical Systems Debt-to-EBITDA Historical Data

The historical data trend for Span-America Medical Systems's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Span-America Medical Systems Debt-to-EBITDA Chart

Span-America Medical Systems Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Span-America Medical Systems Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Span-America Medical Systems's Debt-to-EBITDA

For the Medical Devices subindustry, Span-America Medical Systems's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Span-America Medical Systems's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Span-America Medical Systems's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Span-America Medical Systems's Debt-to-EBITDA falls into.



Span-America Medical Systems Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Span-America Medical Systems's Debt-to-EBITDA for the fiscal year that ended in Sep. 2016 is calculated as

Span-America Medical Systems's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2017) EBITDA data.


Span-America Medical Systems  (NAS:SPAN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Span-America Medical Systems Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Span-America Medical Systems's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Span-America Medical Systems (Span-America Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.
Executives
Terry Allison Rappuhn director P O BOX 58062, NASHVILLE TN 37205
Thomas Joseph Sullivan director 64 PETTIT PL PRINCETON NJ 08540
Robert B Johnston director

Span-America Medical Systems (Span-America Medical Systems) Headlines